Probiosys, subsidiary division of Automed Systems has applied for certification from the Department of Science and Industrial Research (DSIR) as part of its increased focus in the area of rapid microbiology. The certification, according to the company, would help to increase its efforts to carry out advanced rapid microbiology tests for the life-sciences industry. The market for rapid microbiology products in India is expected to grow ten-fold in the next 3 years as organisations begin using it for in process applications. Rapid Microbiology also provides innovative methods for faster detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products.
The study of microbes has advanced to a higher level where rapid microbiology is taking the face of biotechnology. Rapid microbiology is the latest technique which industries across the world are implementing to meet the challenges of better product quality and compliance. In order to expand the market, Probiosys organized a rapid microbiology summit in Bangalore to help the life sciences industry to adopt conventional microbiological assays and the opportunities for implementing new, rapid methods.
Indian companies like Panecea Biotech, Biocon, Glenmark, Apotex, Natural Remedies, Reckitt Benckiser, Gangagen have implemented rapid microbiology processes to stay ahead of the market. “The challenge before us is to tap newer areas and applications like adoption of rapid microbiology in blood banks”, stated Prakash. Rapid Microbiology is an emerging technology and will take some time for Indian companies to adopt it. Within the next 10 years it is going to change people’s perception about microbiology, stated Sourabh Mathur, Business Head, Probiosys.